Coronavirus Update: Novavax Launches Phase III Trial In UK As Virus Surges Back
Plus: Bharat Biotech Licenses Washington University Vaccine
Novavax aims to recruit 10,000 subjects in the UK, and will include a flu vaccination co-administration for some participants.